Disinfectants (Biocides) used in Animal Production: Antimicrobial Resistance Considerations

Preharvest and Postharvest Food Safety: Contemporary Issues and Future Directions

Volumn , Issue , 2008, Pages 227-238

  Beier, Ross C ^a   Bischoff, Kenneth M ^b   Poole, Toni L ^a  

^a SOUTHERN PLAINS AGRICULTURAL RESEARCH CENTER   (United States)

^b NATIONAL CENTER FOR AGRICULTURAL UTILIZATION RESEARCH   (United States)

Author keywords

Biocides; Considerations; Denmark; Disinfectants; Environment

Indexed keywords

EID: 30544445817     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470752579.ch18     Document Type: Chapter

References (90)

1. Aarestrup, F. M. and Wegener, H. C. 1999. The effects of antibiotic usage in food animals on the development of antimicrobial resistance of importance for humans in Campylobacter and Escherichia coli. Microbes and Infection 1:639-644.
2. Acha, P. N. and Szyfres, B. 1987. Zoonoses and Communicable Diseases Common to Man and Animals, 2nd ed. Scientific Publication No. 503. Washington, D.C.: Pan American Health Organization, Pan American Sanitary Bureau, Regional Office of the World Health Organization.
3. Aires, J. R., Kohler, T., Nikaido, H. and Plesiat, P. 1999. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrobial Agents and Chemotherapy 43:2624-2628.
4. Baggesen, D. L. and Wegener, H. C. 1994. Phage types of Salmonella enterica spp. enterica serovar Typhimurium isolated from production animals and humans in Denmark. Acta Veterinaria Scandinavica 35:349-354.
5. Bamber, A. I. and Neal, T. J. 1999. An assessment of triclosan susceptibility in methicillin-resistant and methicillinsensitive Staphylococcus aureus. Journal of Hospital Infection 41:107-109.
6. Bhargava, H. N. and Leonard, P. A. 1996. Triclosan: applications and safety. American Journal of Infection Control 24:209-218.
7. Bischoff, K. M., White, D. G., McDermott, P. F., Zhao, S., Gaines, S., Maurer, J. J. and Nisbet, D. J. 2002. Characterization of chloramphenicol resistance in beta-hemolytic Escherichia coli associated with diarrhea in neonatal swine. Journal of Clinical Microbiology 40:389-394.
8. Block, C., Robenshtok, E., Simhon, A. and Shapiro, M. 2000. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test. Journal of Hospital Infection 46:147-152.
9. Brumfitt, W., Dixson, S. and Hamilton-Miller, J. M. 1985. Resistance to antiseptics in methicillin and gentamicin resistant Staphylococcus aureus. Lancet 1:l442-1443.
10. Boothe, H. W. 1998. Antiseptics and disinfectants. Veterinary Clinics of North America Small Animal Practice 28:233-248.
11. Carlotti, D. N. and Maffart, P. 1996. La chlorhexidine, revue bibliographique. Pratique Médicale et Chirurgicale de l'Animal de Compagnie 31:553-563.
12. Chuanchuen, R., Beinlich, K., Hoang, T. T., Becher, A., Karkhoff-Schweizer, R. R. and Schweizer, H. P. 2001. Cross-resistance between Triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrobial Agents and Chemotherapy 45:428-432.
13. Cookson, B. D. 1994. Antiseptic resistance in methicillin resistant Staphylococcus aureus: an emerging problem? In Staphylococci and Staphylococcal Infections, Proceedings of the 7th International Symposium, Stockhom, Sweden, June 29-July 3, 1992. New York: G. Fischer, pp. 227-234.
14. Das, I., Fraise, A. and Wise, R. 1997. Are glycopeptide-resistant enterococci in animals a threat to human beings? Lancet 349:997-998.
15. Davies, G. E., Francis, J., Martin, A. R., Rose, F. L. and Swain, G. 1954. 1:6-Di-4-Chlorophenyldiguanidohexane ("hibitane"). Laboratory investigation of a new antibacterial agent of high potency. British Journal of Pharmacology 9:192-196.
16. DeSalva, S. J., Kong, B. M. and Lin, Y. J. 1989. Triclosan: a safety profile. American Journal of Dentistry 2:185-196.
17. Donnelly, J. P., Voss, A., Witte, W. and Murray, B. E. 1996. Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans? Journal of Antimicrobial Chemotherapy 37:389-397.
18. Espinasse, J. 1993. Responsible use of antimicrobials in veterinary medicine: perspectives in France. Veterinary Microbiology 35:289-301.
19. Ferber, D. 2000. Superbugs on the hoof? Science 288:792-794.
20. Fitzgerald, K. A., Davies, A. and Russell, A. D. 1992. Sensitivity and resistance of Escherichia coli and Staphylococcus aureus to chlorhexidine. Letters in Applied Microbiology 14:22-36.
21. Furia, T. E. and Schenkel, A. G. 1968. New, broad spectrum bacteriostat. Soap/Cosmetics/Chemical Specialties 44:47-50, 116-122.
22. Grayson, M. (Ed.). 1982. Antibiotics, Chemotherapeutics, and Antibacterial Agents for Disease Control. New York: Wiley.
23. Hamilton, M. A., DeVries, T. A. and Rubino, J. R. 1995. Hard surface carrier test as a quantitative test of disinfection: a collaborative study. Journal of AOAC International 78:1102-1109.
24. Heath, R. J. and Rock, C. O. 2000. A triclosan-resistant bacterial enzyme. Nature 406:145-146.
25. Heath, R. J., Li, J., Roland, G. E. and Rock, C. O. 2000. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene. Journal of Biological Chemistry 275:4654-4659.
26. Heath, R. J., Rubin, J. R., Holland, D. R., Zhang, E., Snow, M. E. and Rock, C. O. 1999. Mechanism of triclosan inhibition of bacterial fatty acid synthesis. Journal of Biological Chemistry 274:11110-11114.
27. Heath, R. J., Yu, Y.-T., Shapiro, M. A., Olson, E. and Rock, C. O. 1998. Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. Journal of Biological Chemistry 273:30316-30320.
28. Hoang, T. T. and Schweizer, H. P. 1999. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. Journal of Bacteriology 181:5489-5497.
29. Holah, J. T., Taylor, J. H., Dawson, D. J. and Hall, K. E. 2002. Biocide use in the food industry and the disinfectant resistance of persistent strains of Listeria monocytogenes and Escherichia coli. Journal of Applied Microbiology 92(Suppl.):111S-120S.
30. Hugo, W. B. 1992. Disinfection mechanisms, pp. 187-210. In Principles and Practice of Disinfection, Preservation and Sterilization, A. D. Russell, W. B. Hugo, G. A. J. Ayliffe (Eds.). Oxford: Blackwell Scientific.
31. Jones, R. D., Jampani, H. B., Newman, J. L. and Lee, A. S. 2000. Triclosan: a review of effectiveness and safety in health care settings. American Journal of Infection Control 28:184-196.
32. Kõljalg, S., Naaber, P. and Mikelsaar, M. 2002. Antibiotic resistance as an indicator of bacterial chlorhexidine susceptibility. Journal of Hospital Infection 51:106-113.
33. Lambert, R. J. W., Joynson, J. and Forbes, B. 2001. The relationships and susceptibilities of some industrial, laboratory and clinical isolates of Pseudomonas aeruginosa to some antibiotics and biocides. Journal of Applied Microbiology 91:972-984.
34. Levy, C. W., Roujeinikova, A., Sedelnikova, S., Baker, P. J., Stuitje, A. R., Slabas, A. R., Rice, D. W. and Rafferty, J. B. 1999. Molecular basis of triclosan activity. Nature 398:383-384.
35. Levy, S. B. 2000. Antibiotic and antiseptic resistance: impact on public health. Pediatric Infectious Disease Journal 19:S120-S122.
36. Levy, S. B. 2001. Antibacterial household products: cause for concern. Emerging Infectious Diseases 7:512-515.
37. Levy, S. B. 2002. Active efflux, a common mechanism for biocide and antibiotic resistance. Journal of Applied Microbiology 92(Suppl.):65S-71S.
38. Levy, S. B., Burke, J. P. and Wallace, C. K. 1987. Antibiotic use and antibiotic resistance worldwide. Reviews of Infectious Diseases 9(Suppl. 3):S231-S316.
39. Li, X.-Z., Zhang, L. and Poole, K. 2000. Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 45:433-436.
40. Ma, D., Cook, D. N., Alberti, M., Pon, N. G., Nikaido, H. and Hearst, J. E. 1993. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. Journal of Bacteriology 175:6299-6313.
41. Maris, P. 1991. Resistance of 700 Gram-negative bacterial strains to antiseptics and antibiotics. Annuales de Recherches Veterinaires 22:11-23.
42. Masuda, N., Gotoh, N., Ishii, C., Sakagawa, E., Ohya, S. and Nishino, T. 1999. Interplay between chromosomal -lactamase and the MexAB-OprM efflux system in intrinsic resistance to -lactams in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 43:400-402.
43. Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H. and Nishino, T. 2000a. Contribution of the MexXMexY- OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 44:2242-2246.
44. Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H. and Nishino, T. 2000b. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 44:3322-3327.
45. Mazzariol, A., Cornaglia, G. and Nikaido, H. 2000. Contributions of the AmpC -lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to -lactams. Antimicrobial Agents and Chemotherapy 44:1387-1390.
46. McCullagh, J. J., McNamee, P. T., Smyth, J. A. and Ball, H. J. 1998. The use of pulsed-field gel electrophoresis to investigate the epidemiology of Staphylococcus aureus infection in commercial broiler flocks. Veterinary Microbiology 63:275-281.
47. McMurry, L. M., McDermott, P. F. and Levy, S. B. 1999. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrobial Agents and Chemotherapy 43:711-713.
48. McMurry, L. M., Oethinger, M. and Levy, S. B. 1998a. Triclosan targets lipid synthesis. Nature 394:531-532.
49. McMurry, L. M., Oethinger, M. and Levy, S. B. 1998b. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiology Letters 166:305-309.
50. Mengistu, Y., Erge, W. and Bellete, B. 1999. In vitro susceptibility of Gram-negative bacterial isolates to chlorhexidine gluconate. East African Medical Journal 76:243-246.
51. Mereghetti, L., Quentin, R., Marquet-Van der Mee, N. and Audurier, A. 2000. Low sensitivity of Listeria monocytogenes to quaternary ammonium compounds. Applied Environmental Microbiology 66:5083-5086.
52. Mølbak, K., Baggesen, D. L., Aarestrup, F. M., Ebbesen, J. M., Engberg, J., Frydendahl, K., Gerner-Smidt, P., Petersen, A. M. and Wegener, H. C. 1999. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. The New England Journal of Medicine 341:1420-1425.
53. Moore, R. A., DeShazer, D., Reckseidler, S., Weissman, A. and Woods, D. E. 1999. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrobial Agents and Chemotherapy 43:465-470.
54. Nicoletti, G., Boghossian, V., Gurevitch, F., Borland, R. and Morgenroth, P. 1993. The antimicrobial activity in vitro of chlorhexidine, a mixture of isothiazolinones ('Kathon' CG) and cetyl trimethyl ammonium bromide (CTAB). Journal of Hospital Infection 23:87-111.
55. Nikaido, H. 1998. Antibiotic resistance caused by Gram-negative multidrug efflux pumps. Clinical Infectious Diseases 27(Suppl. 1):S32-S41.
56. Odore, R., Valle, V. C. and Re, G. 2000. Efficacy of chlorhexidine against some strains of cultured and clinically isolated microorganisms. Veterinary Research Communications 24:229-238.
57. Piddock, L. J. V. 1996. Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic-resistant bacteria that infect man and compromise antimicrobial chemotherapy? Journal of Antimicrobial Chemotherapy 38:1-3.
58. Poole, K. 2000a. Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. Antimicrobial Agents and Chemotherapy 44:2233-2241.
59. Poole, K. 2000b. Efflux-mediated resistance to fluoroquinolones in Gram-positive bacteria and the mycobacteria. Antimicrobial Agents and Chemotherapy 44:2595-2599.
60. Poole, K. 2002. Mechanisms of bacterial biocide and antibiotic resistance. Journal of Applied Microbiology 92(Symp. Suppl.):55S-64S.
61. Prince, H. N., Nonemaker, W. S., Norgard, R. C. and Prince, D. L. 1978. Drug resistance studies with topical antiseptics. Journal of Pharmaceutical Sciences 67:1629-1631.
62. Regös, J. and Hitz, H. R. 1974. Investigations on the mode of action of Triclosan, a broad spectrum antimicrobial agent. Zentralblatt für Bakteriologie, Parasitenkunde, Infecktionskrankheiten und Hygiene-Erste Alteilung Originale-Reihe A: Medizinische Mikrobiologie und Parasitologie 226:390-401.
63. Regös, J., Zak, O., Solf, R., Vischer, W. A. and Weirich, E. G. 1979. Antimicrobial spectrum of Triclosan, a broadspectrum antimicrobial agent for topical application. II. Comparison with some other antimicrobial agents. Dermatologica 158:72-79.
64. Rodgers, J. D., McCullagh, J. J., McNamee, P. T., Smyth, J. A. and Ball, H. J. 2001. An investigation into the efficacy of hatchery disinfectants against strains of Staphylococcus aureus associated with the poultry industry. Veterinary Microbiology 82:131-140.
65. Rosenberg, E. Y., Ma, D. and Nikaido, H. 2000. AcrD of Escherichia coli is an aminoglycoside efflux pump. Journal of Bacteriology 182:1754-1756.
66. Rotter, M. L., Hirschl, A. M. and Koller, W. 1988. Effect of chlorhexidine-containing detergent, non-medicated soap or isopropanol and the influence of neutralizer on bacterial pathogenicity. Journal of Hospital Infection 11:220-225.
67. Royal Pharmaceutical Society of Great Britain. 1997. Resistance to antimicrobial agents: submission to House of Lords subcommittee. Pharmaceutical Journal 259:919-921.
68. Russell, A. D. 1986. Chlorhexidine: antibacterial action and bacterial resistance. Infection 14:212-215.
69. Russell, A. D. 1998. Bacterial resistance to disinfectants: present knowledge and future problems. Journal of Hospital Infection 43(Suppl.):S57-S68.
70. Russell, A. D. 2002. Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. Journal of Applied Microbiology 92(Suppl.):121S-135S.
71. Russell, A. D., Tattawasart, U., Maillard, J.-Y. and Furr, J. R. 1998. Possible link between bacterial resistance and use of antibiotics and biocides. Antimicrobial Agents and Chemotherapy 42:2151.
72. Sanchez, L., Pan, W., Vinas, M. and Nikaido, H. 1997. The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump. Journal of Bacteriology 179:6855-6857.
73. Schweizer, H. P. 1998. Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems. Antimicrobial Agents and Chemotherapy 42:394-398.
74. Seyfarth, A. M., Wegener, H. C. and Frimodt-Møller, N. 1997. Antimicrobial resistance in Salmonella enterica subsp. enterica serovar Typhimurium from humans and production animals. Journal of Antimicrobial Chemotherapy 40:67-75.
75. Sidhu, M. S., Heir, E., Leegaard, T., Wiger, K. and Holck, A. 2002. Frequency of disinfectant resistance genes and genetic linkage with -lactamase transposon Tn552 among clinical Staphylococci. Antimicrobial Agents and Chemotherapy 46:2797-2803.
76. Srikumar, R., Tsang, E. and Poole, K. 1999. Contribution of the MexAB-OprM multidrug efflux system to the -lactam resistance of penicillin-binding protein and -lactamase-derepressed mutants of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 44:537-540.
77. Suller, M. T. E. and Russell, A. D. 1999. Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus. Journal of Hospital Infection 43:281-291.
78. Tattawasart, U., Hann, A. C., Maillard, J.-Y., Furr, J. R. and Russell, A. D. 2000. Cytological changes in chlorhexidine-resistant isolates of Pseudomonas stutzeri. Journal of Antimicrobial Chemotherapy 24:145-152.
79. Tattawasart, U., Maillard, J.-Y., Furr, J. R. and Russell, A. D. 1999. Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. Journal of Hospital Infection 42:219-229.
80. Teale, C. J. 2002. Antimicrobial resistance and the food chain. Journal of Applied Microbiology 92(Suppl.):85S-89S.
81. Threlfall, E. J. 1992. Antibiotics and the selection of food-borne pathogens. Society for Applied Bacteriology Symposium Series 21:96S-102S.
82. Threlfall, E. J. Rowe, B. and Ward, L. R. 1993. A comparison of multiple drug resistance in salmonellas from humans and food animals in England and Wales, 1981 and 1990. Epidemiology and infection 111:189-197.
83. van den Bogaard, A. E. 1997. Antimicrobial resistance-relation to human and animal exposure to antibiotics. Journal of Antimicrobial Chemotherapy 40:453-454.
84. van Klingeren, B. 1995. Disinfectant testing on surfaces. Journal of Hospital Infection 30(Suppl.):397-408.
85. van Leeuwen, W. J., van Embden, J., Guinée, P., Kampelmacher, E. H., Manten, A., van Schothorst, M. and Voogd, C. E. 1979. Decrease of drug resistance in Salmonella in the Netherlands. Antimicrobial Agents and Chemotherapy 16:237-239.
86. Vischer, W. A. and Regös, J. 1974. Antimicrobial spectrum of Triclosan, a broad-spectrum antimicrobial agent for topical application. Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene-Erste Abteilung Originale-Reihe A: Medizinische Mikrobiologie und Parasitologie 226:376-389.
87. Wegener, H. C. 1998. Historical yearly usage of glycopeptides for animals and humans: the American-European paradox revisited. Antimicrobial Agents and Chemotherapy 42:3049.
88. Wegener, H. C., Baggesen, D. L. and Gaarslev, K. 1994. Salmonella typhimurium phage types from human salmonellosis in Denmark 1988-1993. APMIS. Acta Pathologica, Microbiologia, et Immunologica Scandinavica 102:521-525.
89. White, D. G. and McDermott, P. F. 2001. Biocides, drug resistance and microbial evolution. Current Opinion in Microbiology 4:313-317.
90. Zarantonelli, L., Borthagaray, G., Lee, E. H. and Shafer, W. M. 1999. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrobial Agents and Chemotherapy 43:2468-2472.